UnitedHealth sees 78% of members in high-rated Medicare plans

UnitedHealth (UNH) projects 78% of its Medicare members will be enrolled in top-rated (4-star or higher) plans next year, a figure consistent with expectations and better than some investor fears. This outlook propelled UNH shares up 3.21%, as higher star ratings translate to significant government bonus payments, also boosting other health insurers. While the Medicare Advantage sector faces pressures from rising medical costs and tighter reimbursements, UNH is slated to meet with investors this week, where it is expected to reaffirm its 2025 adjusted profit forecast of at least $16 EPS, as it navigates high costs and federal investigations.

Analysis

UnitedHealth's (UNH) preliminary projection that 78% of its members will be enrolled in top-rated Medicare plans next year has provided a significant, albeit temporary, boost to investor confidence. The announcement, which was better than some investors had feared, drove a 3.21% increase in UNH shares to $330.52, as high star ratings directly correlate to substantial government bonus payments, a critical component of profitability. The positive sentiment extended to peers like Elevance (ELV) and Alignment Healthcare (ALHC), which saw gains of 1.3% and 4.7% respectively. However, this outlook must be contextualized within a challenging operating environment characterized by rising medical costs and tighter government reimbursements. Furthermore, UNH is still navigating high costs and federal investigations, placing pressure on management to restore credibility. The upcoming investor meeting, where the company is expected to reaffirm its 2025 adjusted EPS forecast of at least $16, and the official release of CMS 2026 star ratings in October, which will impact 2027 revenues, remain crucial catalysts that will determine the sustainability of this positive momentum.

Key Decisions for Investors

• While UNH's star rating guidance is a positive signal, investors should closely monitor the official Centers for Medicare and Medicaid Services (CMS) data in October and the company's reaffirmation of its $16 EPS forecast for 2025, as these are critical validation points for the current valuation.
• The sector-wide stock lift suggests a positive read-across, but given the industry-wide pressures of rising costs and reimbursement tightening, positions in other health insurers should be evaluated on their individual merits rather than solely on UNH's positive guidance.
• Investors should remain cautious of the material risks associated with UNH, including ongoing federal investigations and cost pressures, which could offset the benefits of strong Medicare Advantage performance and create future volatility.